Company Filing History:
Years Active: 2008-2011
Title: The Innovations of Jong Sang Chung
Introduction
Jong Sang Chung is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of biotechnology, particularly in the purification of interferon beta. With a total of three patents to his name, Chung's work has implications for therapeutic applications in medicine.
Latest Patents
Chung's latest patents focus on processes for purifying human interferon beta from recombinant cultures. One patent describes a method that involves affinity chromatography and cation exchange chromatography. This process includes adsorbing the interferon beta-containing culture to an equilibrated affinity chromatography column, followed by washing with specific buffer solutions. Another patent outlines a similar purification method using affinity chromatography and reversed-phase high-performance liquid chromatography (RP-HPLC). Both patents emphasize the importance of specific pH levels and concentrations of propylene glycol and NaCl in the purification process.
Career Highlights
Throughout his career, Jong Sang Chung has worked with prominent companies such as CJ Cheiljedang Corporation and CJ Corporation. His experience in these organizations has allowed him to develop and refine his innovative techniques in biotechnology.
Collaborations
Chung has collaborated with notable colleagues, including Ki Wan Kim and Myung Suk Oh. These partnerships have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Jong Sang Chung's contributions to the field of biotechnology, particularly in the purification of interferon beta, highlight his innovative spirit and dedication to advancing medical science. His patents reflect a commitment to improving therapeutic processes, making him a significant figure in his field.